Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles-Reference-Cited by-同舟云学术

Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

Published:2022-11 Issue: Volume:77 Page:103868
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Hosseinpour Feizi Abbas Ali,Vakili-Samiani Sajjad,Karpisheh Vahid,Masjedi Ali,Izadi Sepideh,Adibfar Sara,Nikkhoo Afshin,Hojjat-Farsangi Mohammad,Atyabi Fatemeh,Joodi khanghah Omid,Movassaghpour Ali Akbar,Solali Saeed,Yousefi Mehdi,Jadidi-Niaragh Farhad

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Global pediatric oncology: lessons from partnerships between high-income countries and low-to mid-income countries;Ribeiro;J. Clin. Oncol.,2016

2. Relapsed childhood acute lymphoblastic leukaemia;Bhojwani;Lancet Oncol.,2013

3. Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia;Jadidi-Niaragh;Med. Oncol.,2012

4. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis;Yu;Nanoscale,2015

5. Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death;Kim;Pharmacology,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha;Cancer Cell International;2024-06-25

2. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and Hypoxia-inducible factor 1-alpha;2024-01-31

3. Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics;Bioengineering;2023-06-25

4. Dextran-Chitosan Composites: Antioxidant and Anti-Inflammatory Properties;Polymers;2023-04-22